• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

Scientific Publications by FDA Staff

  • Print
  • Share
  • E-mail
-

Search Publications



Fields



Centers











Starting Date


Ending Date


Order by

Entry Details

Nicotine Tob Res 2016 Sep;8(9):1886-94

Mainstream smoke levels of volatile organic compounds in 50 US domestic cigarette brands smoked with the ISO and Canadian intense protocols.

Pazo DY, Moliere F, Sampson MM, Reese CM, Agnew-Heard KA, Walters MJ, Holman MR, Blount BC, Watson C, Chambers DM

Abstract

INTRODUCTION: A significant portion of the increased risk of cancer and respiratory disease from exposure to cigarette smoke is attributed to volatile organic compounds (VOCs). In this study, 21 VOCs were quantified in mainstream cigarette smoke from 50 U.S. domestic brand varieties that included high market share brands and two Kentucky research cigarettes (3R4F and 1R5F). METHODS: Mainstream smoke was generated under ISO 3308 and Canadian Intense (CI) smoking protocols with linear smoking machines with a gas sampling bag collection followed by SPME/GC/MS analysis. RESULTS: For both protocols, mainstream smoke VOC amounts among the different brand varieties were strongly correlated between the majority of the analytes. Overall, Pearson correlation (r) ranged from 0.68 to 0.99 for ISO and 0.36 to 0.95 for CI. However, monoaromatic compounds were found to increase disproportionately compared to unsaturated, nitro, and carbonyl compounds under the CI smoking protocol where filter ventilation is blocked. CONCLUSIONS: Overall, machine generated "vapor phase" amounts (microg/cigarette) are primarily attributed to smoking protocol (e.g., blocking of vent holes, puff volume, and puff duration) and filter ventilation. A possible cause for the disproportionate increase in monoaromatic compounds could be increased pyrolysis under low oxygen conditions associated with the CI protocol.


Category: Journal Article
PubMed ID: #27113015 DOI: 10.1093/ntr/ntw118
Includes FDA Authors from Scientific Area(s): Tobacco
Entry Created: 2016-04-27 Entry Last Modified: 2016-11-12
Feedback
-
-